Download PDF
Nuklearmedizin 1972; 11(03): 226-233
DOI: 10.1055/s-0038-1624787
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

Observations on the Therapeutic Merit of Thyroid Radioablation for Treatment of Malignant Exophthalmos

Observation sur la valeur thérapeutique de l’élimination radiologique de la thyroide dans le traitement de l’exophthalmie maligneBeobachtungen über den therapeutischen Wert einer Strahlenausschaltung der Schilddrüse in der Behandlung des malignen Exophthalmus
E. R. Weiss
1   From the Nuclear Medicine Service, Veterans Administration Hospital (Wadsworth, Los Angeles) and the Departments of Medicine, UCLA School of Medicine, and USC School of Medicine, Los Angeles
,
W. H. Blahd
1   From the Nuclear Medicine Service, Veterans Administration Hospital (Wadsworth, Los Angeles) and the Departments of Medicine, UCLA School of Medicine, and USC School of Medicine, Los Angeles
,
M. A. Winston
1   From the Nuclear Medicine Service, Veterans Administration Hospital (Wadsworth, Los Angeles) and the Departments of Medicine, UCLA School of Medicine, and USC School of Medicine, Los Angeles
,
G. T. Krishnamurthy
› Author Affiliations
Further Information

Publication History

Received:05 May 1972

Publication Date:
15 January 2018 (online)

    Permissions and Reprints

7 malades atteints par une exophthalmie sévère ont été traités par des doses elevées de 131I pour les symptômes oculaires. Dans 6 malades on a obtenue une amélioration. Dans 1 malade les conditions restaient stables malgré la persistance de function de la Atyroide demontrée par la scintigraphic. Les résultats obtenues semblent de montrer que l’élimination radiologique pour traitement de l’exophthalmine maligne n’offre pas des avantages sur les formes de thérapie actuellement en usage.

Summary

Seven patients with severe exophthalmos received ablative doses of 131I in an attempt to ameliorate their eye disease. Six patients improved and the seventh patient remained stable despite the continued presence of functioning thyroid tissue on follow-up scintigrams. The results of this study would appear to indicate that radioablation for the treatment of malignant exophthalmos offers no advantages over present modes of therapy.

Sieben Patienten mit schwerem Exophthalmus erhielten hohe Dosen von 131J, um ihre Augenerkrankung zu bessern. Bei sechs Patienten trat eine Besserung ein und der siebente Patient blieb unverändert, obwohl der Fortbestand von funktionierendem Schilddrüsengewebe szintigraphisch nachgewiesen werden konnte. Die Ergebnisse diesere Untersuchungen scheinen zu zeigen, daß die Strahlenausschaltung in der Behandlung des malignen Exophthalmus keine Vorteile gegenüber den derzeitigen Therapieformen bietet.

 

  • References

  • 1 Burke G. Long acting thyroid stimulator and exophthalmos. Ann. Intern. Med. (Editorial) 1969; 70: 1045.
    CrossrefGoogle Scholar
  • 2 Burke G. The long-acting thyroid stimulator of Graves' disease. Amer. J. Med. 1968; 45: 435.
    CrossrefGoogle Scholar
  • 3 Bauer F. K., Blahd W. H. Treatment of hyperthyroidism with individually calculated doses of 131I. Arch. Intern. Med. 1957; 99: 194.
    CrossrefGoogle Scholar
  • 4 Bauer F. K., Catz B. Radioactive iodine therapy for progressive malignant exophthalmos. Acta Endocr. 1966; 51: 15.
    Google Scholar
  • 5 Catz B., Perzik S. L. Total thyroidectomy in the management of thyrotoxic and euthyroid Graves' disease. Amer. J. Surg. 1969; 118: 434.
    CrossrefGoogle Scholar
  • 6 Catz B., Perzik S. L. Subtotal versus total surgical ablation of the thyroid. Malignant exophthalmos and its relation to remnant thyroid. Current Topics in Thyroid Research, Proceedings of the Fifth International Thyroid Conference, 1965; 1183.
    Google Scholar
  • 7 Conklin W. H., McClintock J. C., Baxter D. H., Peck Jr. F. C. Management of exophthalmos. Amer. Surgeon 1960; 26: 582.
    Google Scholar
  • 8 Kriss J. P. The long-acting thyroid stimulator. Calif. Med. 1968; 109: 202.
    Google Scholar
  • 9 Ochi Y., DeGroot L. J. Long acting thyroid stimulator of Graves' disease. New Eng. J. Med. 1968; 718: 718.
    Google Scholar
  • 10 Pequegnat E. P., Mayberry W. E., McConahey W. M., Wyse E. P. Large doses of radioiodine in Graves' disease: Effect on ophthalmopathy and long acting thyroid stimulator. Mayo Clin. Proc. 1967; 43: 802.
    Google Scholar
  • 11 Rle F. F. Management of exophthalmos and related ocular changes in Graves' disease. Metabolism 1957; 6: 36.
    Google Scholar
  • 12 Volpe R., Desbarats - Schonbaum M. L., Schonbaum E., Row V. V., Ezrin C. The effect of radioablation of the thyroid gland in Graves' disease with high levels of long-acting thyroid stimulator (LATS). Amer. J. Med. 1969; 46: 217.
    CrossrefGoogle Scholar
  • 13 Werner S. C. Prednisone in emergency treatment of malignant exophthalmos. Lancet 1966; 1: 1004.
    Google Scholar
  • 14 Werner S. C., Feind C. R., Aida M. Graves' disease and total thyroidectomy. New Eng. J. Med. 1967; 276: 132.
    CrossrefGoogle Scholar